Export

Efavirenz + emtricitabine + tenofovir
Essential medicine status
General description
efavirenz + emtricitabine + tenofovir is a fixed-dose combination of nucleotide/nucleoside analog reverse-transcriptase inhibitors (NRTIs) used to prevent and treat HIV/AIDS
INN
Efavirenz + emtricitabine + tenofovir
Medicine type
Chemical agent
Therapeutic equivalent for
Recommendations
Section
Fixed-dose combinations of antiretrovirals
  • Oral > Solid: 600 mg + 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)